Podcasts

Episode 96: PD Medications and Side Effects

Adverse effects, often called side effects, are a common phenomenon that accompanies the use of many drugs, including ones used to treat the symptoms of Parkinson’s disease (PD). Any treatment is a balance between the desired effects of a drug and undesirable ones, so how to best ease symptoms while making the treatment tolerable. Specific to classes of drugs used for PD, some of the side effects may be drowsiness, insomnia, light headedness, hallucinations, cognitive impairment, swelling of the legs, dry mouth, weight gain, compulsive behavior, and others. These are just possibilities, and a good working relationship with a PD health care team can help avoid many of them. Beyond the PD team, keeping other health care providers informed is advisable since drug interactions can occur, so all practitioners (including dentists) should be aware of all medications that a person is taking, prescription, over-the-counter and even supplements.

In this podcast episode, neurologist Dr. Irene Richard of the University of Rochester Medical Center discusses several of the various drugs and drug classes used to treat the symptoms of PD in relation to the adverse effects that can accompany them. She offers insights into several ways to avoid or minimize adverse effects of drug therapy, what clinicians should tell people starting a new drug, and what people should ask as well as be aware of and report back.

Released: December 29, 2020

Podcasts

Episode 134: Meet the Researcher: Disparities in PD Care

As with many medical conditions, people with Parkinson’s disease (PD) may experience disparities in access to care, in diagnosis, treatments, and ancillary care. These disparities may be based on age, gender, race, financial situation, language barriers, and geographic location, among other factors. Dr. Lynda Nwabuobi, now a movement disorders specialist at New York-Presbyterian/Weill Cornell Parkinson’s Disease and Movement Disorders Institute in New York City, received her specialized training at Columbia University, supported by a Parkinson’s Foundation Movement Disorders Fellowship.

During her training, she noticed that women with PD who were home bound were more likely than men to be alone and to have less access to a neurologist. She also recognized disparities in the care between the majority white population of people with PD seen at the main hospital clinic of New York University (NYU) compared to the more racially diverse, multicultural community of people seen at NYU’s public Bellevue Hospital nearby – even though they were being treated by the same doctor. In this podcast episode, she describes how she acted on her passion of “creating access to better care to marginalized communities and bring more diversity to the clinic.” Rather than waiting for the community to come to the health care setting, she reached out to them on their turf — at a farmers’ market.

Released: August 9, 2022

My PD Story

Hannah Griffiths
Health Professionals

Hannah Griffiths

My name is Hannah Griffiths, and I am both a healthcare professional and a family member of someone living with Parkinson’s disease (PD). My father, William, was diagnosed more than 10 years ago, and at that time, our family had little understanding of what the diagnosis truly meant.

Even as a Registered Nurse with several years of experience, I found myself uncertain about the intricacies of the disease. His diagnosis profoundly influenced me, inspiring my commitment to support not only my parents — my father as a patient and my mother as his primary caregiver — but also others affected by Parkinson’s.

About nine years ago, while driving home from work, I heard a radio announcement for the Parkinson’s Foundation Moving Day walk. Our family decided to participate that year, and it quickly became an annual tradition.

I encourage anyone impacted by Parkinson’s to attend Moving Day, as the event offers an incredible opportunity to experience firsthand the sense of community, support and resources available.

I currently serve as an Instructor of Clinical Nursing at the University of Rochester School of Nursing, a Parkinson’s Foundation Center of Excellence, where I teach in both lab and clinical settings.

Hannah Griffiths with her parents

Recently, I had the privilege of attending the Edmond J. Safra Nurse Educator Program on Parkinson’s Disease in Philadelphia, PA. During this program, I collaborated closely with providers in a movement disorders clinic and observed the highly specialized, patient-centered care delivered to people with PD.

The PD experts generously shared their clinical insights, and I was able to observe patient appointments that demonstrated the holistic and multidisciplinary nature of Parkinson’s care.

This experience has deepened my understanding and passion for improving PD education. I am eager to integrate what I have learned into our nursing curriculum to better prepare future nurses to deliver high-quality, compassionate care to the Parkinson’s community.

Find expert Parkinson’s care near you. Find your closest designated center in our Global Care Network or call our Helpline at 1-800-4PD-INFO (1-800-473-4636) for local referrals.  

Advancing Research

Meet the Researcher Working to Develop an Imaging Biomarker for Parkinson’s

🧠 What will you learn in this article?

This article highlights a researcher working to develop a biomarker tag called a PET tracer for Parkinson’s disease (PD). It discusses: 

  • What a PET tracer is and how it could track misfolded alpha-synuclein clumps.

  • How a PET tracer could track disease progression and test therapies.

  • How support from the Parkinson’s Foundation makes research like this possible.

Sarah Shahmoradian headshot

Tracking Parkinson’s disease (PD) progression is challenging, and doctors currently rely on how a person’s symptoms change over time. This method is difficult because symptoms vary from person to person and can fluctuate, making it hard to evaluate if treatments are helping.

For other brain diseases like Alzheimer’s, scientists have developed small molecules that can attach to disease-related protein clumps and make them visible on brain scans such as PET (positron emission tomography). These imaging tools allow researchers and clinicians to see where harmful proteins are building up in the brain, providing a clearer way to track disease progression and test therapies. In short, these imaging tools can act as a biomarker for the disease.

What is a biomarker?

Biomarkers are biological signs that can be measured to help diagnose a disease, track its progression and evaluate if treatments are working.

Sarah Shahmoradian, PhD, recipient of a Parkinson’s Foundation Impact Award, is exploring whether a similar biomarker tag could work for Parkinson’s. Working with collaborators at Massachusetts General Hospital, a Parkinson’s Foundation Center of Excellence, Dr. Shahmoradian is studying a specially designed small molecule that appears to bind to toxic forms of the protein connected to Parkinson’s (called alpha-synuclein). 

“Currently, we do not have a PET tracer that reliably marks clusters of the protein alpha-synuclein when it goes bad, so we can’t tell when these clusters are starting to grow or when they are starting to spread in the brain,” said Dr. Shahmoradian.

Having a Parkinson’s-specific PET tracer to track the alpha-synuclein protein would help PD doctors and care teams:

  • Detect Parkinson’s earlier

  • Monitor how PD spreads over time

  • Evaluate if experimental therapeutics are reducing the clustering and accumulation over time

  • Distinguish Parkinson’s from other conditions with overlapping symptoms

From her lab at the University of Texas Southwestern Medical Center in Dallas, Dr. Shahmoradian will use high-resolution imaging methods — developed through her earlier research, which was supported by a Parkinson’s Foundation Stanley Fahn Junior Faculty Award in 2022 — to see precisely how this new molecule attaches to alpha-synuclein. Understanding this interaction at the molecular level will help scientists fine-tune the tracer for future clinical imaging.

The next step is to adapt the molecule so it glows under the microscope. By applying it to neurons grown in the lab that model Parkinson’s disease, or to slices of PD brain tissue, Dr. Shahmoradian and her team hope to track where alpha-synuclein clumps appear and how they move inside cells.

If successful, this work will demonstrate that the molecule can serve as a powerful diagnostic and research tool for Parkinson’s.

“There is real momentum in Parkinson’s disease research right now. We understand more about the problematic protein alpha-synuclein now than we did a decade ago. Cell models are becoming increasingly sophisticated and there are newer imaging agents and disease-modifying therapies on the horizon.” - Dr. Shahmoradian

Dr. Shahmoradian believes her work brings hope to the Parkinson’s community because through it, researchers like herself can look at problematic alpha-synuclein clumps at extremely high resolution to figure out exactly where the protein goes wrong.

She is grateful for the community she has found through the Parkinson’s Foundation, and the connections she has made with other researchers who are also focused on finding a cure for Parkinson’s disease.

“This research would not be possible without the Foundation’s support, and the donors who made these grants a reality. Your investment is not abstract. You are helping support experiments right now, in real time, that help diagnose and treat Parkinson’s disease. You are accelerating and empowering scientists like myself toward the shared common cause of curing Parkinson’s disease,” said Dr. Shahmoradian.

Meet more Parkinson’s researchers! Explore our My PD Stories featuring PD researchers.

My PD Story

Lynn Scott climbing stairs
Health Professionals

Lynn Scott

I am a clinical assistant professor at the University at Buffalo’s School of Nursing in the Family Nurse Practitioner Program. I was extremely fortunate to be chosen to be an attendee at the Edmond J. Safra Nurse Educator at Parkinson’s Foundation Fellowship in 2025 at the Parkinson Disease and Movement Disorders Center at the University of Pennsylvania, a Center of Excellence.

The process of acceptance started six months before the fellowship. Once notified, I completed highly informative and eye-opening learning modules including the Fundamentals of Parkinson’s for Professionals, Expert Care Experience: The Role of Nurses in Caring for Patients with Parkinson’s, and Hospitalization in Parkinson’s Disease through the Parkinson’s Foundation Learning Lab.

Why was I interested in this fellowship? We are all, in one way or another, affected by Parkinson’s disease (PD). We all know or will know someone in the future who has the disease.

Throughout the many years of my nursing education, I learned about the pathophysiology of PD and the pharmacology of the few medications that exist. Given all that we had to learn about the neurological system, it was a brief and cursory introduction to the disease. As a lifelong learner, I wanted to obtain as much information about PD as possible because, as a committed nursing educator, I wanted to broaden my students’ knowledge base about providing care for their patients affected by this disease.

I traveled with a colleague to Philadelphia, and the weather was warm — an autumnal gift. We explored the city and familiarized ourselves with the local attractions and cuisine. We arrived at the center Monday morning, eager to go with a good cup of local coffee in hand.

We had a full day of didactics from the clinic’s top specialists in PD and Movement Disorders. To say that we were overwhelmed, even as educators ourselves, was an understatement. We delved into all things Parkinson’s: alpha synuclein, DaTscans, bradykinesia and tremors, “on time” and “off time,” movement vs. non-movement symptoms, Sinemet, dopamine agonists, and catechol-o-methyltransferase inhibitors.

We experienced firsthand the high demand on our nursing students’ bodies and brains that learning imposed. We were full of information and questions by the end of the day, all of which were addressed and answered during the immersion as observant clinicians into the everyday functioning of the clinic for the next two days.

Tuesday arrived, and we arrived with extra coffee on board. The hospitality of Penn Medicine and the welcoming nature of the patients and families embraced us as though we were employees, not just observers into the very private nature of life with PD. We were assigned to movement disorders physicians who were hosting medical school students, residents and fellows.

We attended patient appointments. We listened, observed and learned all the things that we could not or would ever learn about PD in nursing school. Even the neurologists said their experiences were similar in medical school — just too much to learn about the neurological system, too many conditions, and so little time.

During the two days in the clinic, I observed how Botox injections helped with severe foot cramps, adjustments of carbidopa-levodopa, introduction of adjunctive therapies, some pharmacological and some therapeutic and deep brain stimulation (DBS) adjustments. I watched in awe of the impact that the tiniest micro-adjustment of the DBS had on symptoms — a worsening of speech but an improvement in tremors, and then the sweet spot that instantly improved the patient’s symptoms and, thus, quality of life. I attended physical therapy sessions where patients and their families were educated about the importance and impact of exercise on slowing the progression of PD.

After returning home to digest everything, I had the opportunity to attend a support group, also hosted by Penn Medicine, for those new to PD. All the supportive resources (social work, physical therapy, occupational therapy, speech therapy, clinical trial opportunities, and treatment options) that were highlighted made me aware of the incredible advances that support and treat people with PD.

It became a mission to extend our nursing curriculum to include some of the most important things our nursing students and healthcare providers can learn — the importance of maintaining PD patients’ medication schedules, the promotion of mobility and exercise, and fall prevention during hospitalization.

Since attending the fellowship, my colleague and I presented this information to our entire nursing faculty. Our educators were amazed at how little they had learned in their education and how this had been perpetuated in nursing education. In addition, the National Council of State Boards of Nursing was contacted, provided with some of the information we obtained during our fellowship, and was asked to consider including even two of the NCLEX Board questions on caring for PD patients while in the hospital.

It is my hope that, by sharing this incredible eye-opening experience, other nurse educators will apply for these fellowships that are held throughout the year and throughout the U.S. It is an amazing opportunity!

I promise that you will not return without the desire to broaden the knowledgebase of your students with the goal of improving the lives of people with PD.

Explore our vast resources for professionals — from special programs to virtual Learning Lab courses, complete with continuing education credits. 

Videos & Webinars

Latest Advances in Parkinson’s Treatments: What Veterans Need to Know

April 23, 2026

The landscape of Parkinson’s treatment is constantly evolving, with exciting advances in medications, therapies, and technologies aimed at improving quality of life and symptom management. In this webinar, we’ll explore the latest evidence-based treatments available to veterans living with Parkinson’s, including emerging therapies and clinical trial opportunities. Learn how to access treatments through the VA system and understand which options may be right for you or your loved one. This session is designed to empower veterans and care partners with up-to-date knowledge and tools for informed decision-making.

Download Slides

Additional Resources

Presenters

Dr. Pavan Vaswani 
Associate Program Director, Movement Disorders Fellowship, Department of neurology, University of Pennsylvania
Attending Neurologist, Corporal Michael J. Crescenz Philadelphia VA Medical Center, University of Pennsylvania 

Dr. George Kannarkat
Assistant Professor of Neurology, Hospital of the University of Pennsylvania
Neurology Consultant, Penn Neurology, Grandview Hospital, Sellersville, PA

Fact Sheets

Therapies to Help You Live Better with Parkinson's

Physical, occupational and speech therapy can help manage symptoms and support daily life with Parkinson’s disease (PD). These therapies are a key part of PD care.

When should therapy start?

People often begin therapy when symptoms become more noticeable, but it can help at any stage of Parkinson’s. Starting therapy early and continuing over time is especially helpful.

Think of it like going to the dentist for checkups — regular visits help prevent problems, not just treat them.

How does therapy help?

Physical, occupational and speech therapists focus on different parts of daily life.

Physical therapy helps with:

  • Walking and overall movement

  • Balance and fall prevention

  • Strength and flexibility

  • Exercise and staying active

Occupational therapy helps with:

  • Daily tasks like dressing, cooking, driving and using technology

  • Home setup for safety and comfort

  • Staying involved in work, hobbies and daily routines

Speech therapy helps with:

  • Speech and voice

  • Thinking and communication skills

  • Everyday conversations

  • Swallowing (food, drinks and pills)

Do I need all three types of therapy?

A visit with each can help you establish a baseline (a clear picture of your current abilities), connect with a therapist you can work with over time and decide where to start.

How does therapy work?

Therapy is based on your needs and goals. It often focuses on small changes to help keep movement, daily tasks and communication as smooth as possible. It can also address specific Parkinson’s challenges. Here’s what to expect:

Step 1: Talk with your care team

Tell your care team you are interested in physical, occupational or speech therapy. A referral is often needed. Your care team may be able to suggest therapists trained in Parkinson’s care.

Step 2: Meet with your therapist and set goals

At your first appointment, your therapist will look at your abilities and needs. Together, you will set realistic goals based on what matters most to you right now. These might include building strength, walking more steadily, managing daily tasks like dressing or eating or speaking louder.

Step 3: Continue therapy and practice at home

Therapy may be a few sessions or continue over several weeks or longer, depending on your needs and goals. You will likely have exercises to do at home. Let your therapist know what is working and what is not so your program can be adjusted as needed.

Step 4: Schedule follow-up visits

Follow-up visits help track your abilities, review goals and adjust strategies and exercises as needed. Many people check in with a therapist about once a year, or more as needed. These visits help you notice new challenges and address them early.

Fact Sheets

How to Add Palliative Care to Your Parkinson's Plan

Palliative care is extra support for anyone living with a serious illness, such as Parkinson’s. It helps manage symptoms and supports emotional well-being. The goal is to improve quality of life for you and your care partners.

Palliative care can help you:

  • Manage difficult symptoms such as pain, anxiety and constipation

  • Cope with the stress and emotional impact of illness

  • Support your care partner with education and counseling

  • Plan for future care and make decisions as your needs change

How does palliative care work?

Palliative care can be part of your regular care. In some settings, it involves a specialized team that may include nurses, social workers, chaplains and other health professionals. It often starts with a conversation about what matters most to you, followed by a plan to address those needs. It does not replace your current treatment.

When should I get palliative care?

Palliative care can be helpful at any stage of Parkinson’s, even soon after diagnosis. You might consider palliative care if symptoms are hard to manage, daily life feels overwhelming or you want help planning ahead. It is not limited to hospice or end-of-life care.

How can I get palliative care?

  • Ask about palliative care at your next medical visit. If you are in the hospital, in rehabilitation or receiving home health services, ask if palliative care is available.

  • Visit www.getpalliativecare.org to find services near you. Many palliative care agencies offer support at any stage of illness.

Will my insurance cover palliative care?

Medicare typically covers many palliative care services. Coverage through Medicaid and private insurance depends on your state and your plan. Check with your insurance company.

What if there are no palliative care services where I live?

Palliative care services are growing, but they may not be available in every area. You and your care team can still work together to focus on your comfort, emotional support and quality of life.

If you don't have palliative care services near you, here are four ways to advocate for more supportive PD care:

1. Manage symptoms

  • Prepare for Parkinson's appointments. Before each visit, identify the three things that matter most to you to discuss with your care team.

  • Ask for referrals to specialists. If certain symptoms are hard to manage, ask for a referral to a specialist with expertise in that area.

2. Support care partners

  • Work as a team. Share emotional and physical challenges. Learn about Parkinson’s and caregiving together. Talk with your care team and support network about help you may need now and in the future.

3. Care for emotional or spiritual health

  • Reach out to others. Talk with a support group, counselor, spiritual advisor or trusted friend. These relationships can provide a safe space to share and help you cope with Parkinson’s.

4. Plan for future care

  • Think ahead. Reach out to others. Talk with a support group, counselor, spiritual advisor or trusted friend. These relationships can provide a safe space to share and help you cope with Parkinson’s.

  • Document your choices. Complete advanced care directives, such as a healthcare proxy or living will to make your wishes known if you cannot speak for yourself.

Raise Awareness

Temblores, estremecimientos y todo lo demás: enfrentando los síntomas motores del Parkinson

🧠 ¿Qué aprenderá en este artículo?

  • Los síntomas motores (movimiento) pueden afectar casi todos los aspectos de la vida de las personas con Parkinson.

  • Descubra cómo el ejercicio, los medicamentos y las terapias pueden ayudar a las personas con la enfermedad de Parkinson a moverse con mayor facilidad en cada etapa.

  • Los síntomas —incluyendo el temblor, la rigidez (agarrotamiento), la bradicinesia, la distonía, los problemas de marcha y equilibrio, y los cambios en el habla— se deben a la pérdida progresiva de las neuronas que producen ‑dopamina.

  • El ejercicio y los medicamentos (especialmente la levodopa) son los tratamientos más eficaces.

Pareja de personas mayores estirando al aire libre

La enfermedad de Parkinson (EP) puede dificultar moverse cuando quiera, de la manera en que quiera y puede ser igual de difícil mantenerse quieto. Desde el temblor y la rigidez hasta los calambres musculares y la dificultad para caminar, los problemas motores pueden afectar todos los aspectos de la vida diaria en la enfermedad de Parkinson. Descubra cómo el ejercicio, los medicamentos y otras estrategias pueden ayudarle a moverse con mayor facilidad.

El siguiente artículo se basa en una de las Charlas con Expertos - Expert Briefings de la Parkinson's Foundation, que explora los síntomas motores en la EP, presentada por el especialista en trastornos del movimiento, el Dr. Pablo Coss, de la residencia de Neurología y la subespecialidad en trastornos del movimiento del University of Texas Health Science Center at San Antonio, parte de la Red Global de Atención de la Parkinson’s Foundation.

Puntos clave para el Parkinson

La enfermedad de Parkinson se denomina un trastorno del movimiento porque afecta la forma en que la persona se mueve. Aunque los síntomas suelen desarrollarse lentamente con el tiempo, el Parkinson es progresivo; las necesidades pueden cambiar a medida que la EP avanza a través de sus etapas. La historia de una persona, sus síntomas y el examen físico se utilizan para hacer el diagnóstico.

Para considerar un diagnóstico de la enfermedad de Parkinson, debe estar presente la lentitud de movimiento (bradicinesia) junto con alguno de los siguientes:

  • Temblor en reposo: movimiento rítmico e involuntario que tiende a ocurrir cuando la parte del cuerpo afectada está en reposo. Esto tiende a afectar un lado del cuerpo en las etapas tempranas de la EP.

  • Rigidez (agarrotamiento): resistencia al movimiento causada por la activación involuntaria de los músculos en reposo.

  • Problemas de equilibrio (inestabilidad postural) que provocan tropiezos y caídas. 

Dopamina y movimiento

Aunque los científicos aún trabajan para comprender las causas del Parkinson, sabemos que se trata de un trastorno cerebral progresivo que daña las neuronas productoras de dopamina. La dopamina es un mensajero químico que regula el estado de ánimo y ayuda al cuerpo a moverse con fluidez.

Cambios motores en la EP

La pérdida de dopamina en una zona del cerebro llamada sustancia negra y otros cambios químicos en la enfermedad de Parkinson interfieren con las señales cerebrales, lo que provoca muchos síntomas no motores —incluidos cambios emocionales, problemas gastrointestinales y fatiga— y afecta el movimiento de distintas maneras, entre ellas:

  • Bradicinesia: lentitud de movimiento que puede afectar a todo el cuerpo, causando fatiga y dificultad para caminar o realizar actividades cotidianas. También puede causar: 

    • Enmascaramiento facial: rigidez en los músculos del rostro que dificulta expresar emociones.

    • Desafíos con movimientos de las manos, lo que dificulta más hacer cosas como abrir una bolsa, abrir un envase o escribir. La micrografía, escritura pequeña y amontonada que se ve frecuentemente a principios de la EP, suele estar conectada con la lentitud de movimiento.

    • Dificultad para ponerse de pie después de estar sentado.

  • Temblor. Las personas con Parkinson suelen tener temblor en reposo en una mano, pero también puede afectar las piernas, la mandíbula o la cara. El temblor de la mano suele describirse como “pill-rolling”, como si la persona estuviera haciendo rodar una pastilla entre el pulgar y el índice.

Alrededor de un 70% de las personas con Parkinson experimentan temblores. Para algunos, los temblores son leves, pero para otros pueden causar inseguridad e interferir con el sueño y las tareas diarias.

El temblor de acción, otro síntoma de la EP, sucede cuando la parte del cuerpo afectada está moviéndose o tratando de hacer una tarea como escribir o tomar de un vaso. Muchas personas con Parkinson experimentan una combinación de temblor de acción y de reposo.

  • La rigidez, que a veces se describe como “rigidez en tubo de plomo”: la resistencia del cuerpo al movimiento durante un examen físico (cuando está relajado) puede ser tan fuerte que puede sentirse como si el examinador intentara doblar un tubo de metal pesado. La rigidez puede conducir a:

    • Molestias dolorosas y dificultad para dormir

    • Menor movimiento de brazos y piernas al caminar

    • Rigidez facial

  • Distonía; calambres y retorcimientos musculares dolorosos y repetitivos, frecuentes en Parkinson, pueden:

    • hacer que los dedos se engarroten o mantengan una posición anormal

    • provoquen que el tobillo se gire hacia adentro naturalmente y que los dedos se giren

    • impactar la cara y los ojos, dificultando para algunos abrir los ojos de manera voluntaria

    • ir acompañado de un movimiento que puede sobreponerse con otras formas de temblor de la EP

  • Hipofonía (problemas del habla) puede incluir un habla suave o arrastrada, dificultades con la articulación, menor volumen o monotonía al hablar lo que, — a la par de la rigidez facial—, puede ser que la expresión emocional sea un desafío. Hipofonía también puede provocar respiraciones poco profundas, vacilantes, acelerada.

  • Marcha parkinsoniana—Cambios en la forma en que camina una persona debido a la EP, provocando pasos pequeños arrastrados, hombros encorvados, menor balanceo de los brazos o dificultad para levantar los pies.

Estos problemas de equilibrio y de la marcha, —junto con pasos cortos y rápidos que tienden a acelerarse (festinación), inclinación hacia atrás y falta de equilibrio—, aumentan el riesgo de caídas y lesiones, al igual que la congelación de la marcha: una sensación temporal pero peligrosa de que los pies están pegados al suelo. Las áreas concurridas, las puertas y los umbrales pueden desencadenar el congelamiento de la marcha.

Aumentar la dopamina: ejercicio y medicamentos

Woman taking medication

Debido a que la pérdida de dopamina impulsa los síntomas motores del Parkinson, aumentar la dopamina es la forma más eficaz de manejarlos y el ejercicio es una de las maneras más simples de ayudar a incrementarla y ralentizar la progresión de la enfermedad.

El ejercicio puede aliviar los síntomas motores del Parkinson y mejorar la fuerza y el equilibrio. Encontrar un ejercicio que disfrute puede darle la motivación para mantenerse activo. Nuestros ejercicios Viernes de Ejercicio de EP Salud en Casa, una colección de videos de ejercicio adaptados para personas con Parkinson, pueden ayudar a mantenerlo activo en casa.

La levodopa es el tratamiento más eficaz para la enfermedad de Parkinson. Las células cerebrales metabolizan la levodopa para convertirla en dopamina. Se suele combinar con carbidopa; esto permite que una mayor cantidad de levodopa llegue al cerebro sin ser metabolizada primero en el intestino (donde puede causar náuseas).

Para mantener los niveles necesarios de dopamina que ayuden al cuerpo a funcionar de manera óptima, es fundamental tomar los medicamentos exactamente como se prescriben. Es común que el médico ajuste la dosis a medida que la enfermedad de Parkinson progresa, para manejar los cambios en los síntomas.

Existen muchas formulaciones de levodopa, entre ellas:

  • Liberación inmediata (Sinemet IR), a menudo recetada en tres o más dosis al día.

  • Liberación controlada (Sinemet CR), a menudo recetada en tres o más dosis al día. 

  • Las formulaciones más recientes de liberación prolongada (Rytary o Crexont) pueden ofrecer efectos más rápidos y de mayor duración. Estas pueden recetarse de dos a cuatro veces al día.

  • Las terapias con bomba administran un suministro continuo de medicamento:

    • Vyalev administra foscarbidopa/foslevodopa mediante una bomba portátil y una aguja insertada debajo de la piel.

    • Duopa proporciona un gel continuo de carbidopa/levodopa a través de una sonda colocada quirúrgicamente.

  • La levodopa inhalada (Inbrija) se utiliza según sea necesario para tratar la reaparición de los síntomas entre las dosis regulares de carbidopa/levodopa, de cuatro a cinco veces al día.

Los efectos secundarios de la levodopa pueden incluir: nausea, estreñimiento, mareo, baja presión arterial, somnolencia, alucinaciones, o cambios en el comportamiento, como la hipersexualidad (trastorno de control de impulsos.)

Con el tiempo, algunos medicamentos para el Parkinson también pueden causar movimientos irregulares (discinesia), incluidos retorcimiento, balanceo, contorsiones y movimientos tipo “baile”. Esto puede ocurrir con frecuencia después de tomar una dosis, cuando la levodopa alcanza su máxima eficacia en el cuerpo.

Progresión del Parkinson, fluctuaciones motoras y tratamientos avanzados

Aunque la enfermedad de Parkinson afecta a cada persona de manera diferente, a medida que avanza, en muchas personas la reaparición o el empeoramiento de los síntomas (fluctuaciones motoras o periodos en “off”) entre las dosis de los medicamentos puede ocurrir con mayor frecuencia. Esto puede provocar un aumento de la discinesia, el desequilibrio o las caídas, o la necesidad de dispositivos de asistencia — herramientas diseñadas para mejorar la vida diaria.

Hable con su médico acerca de sus inquietudes. Él o ella puede trabajar con usted para ajustar su medicación o explorar tratamientos avanzados.

Los medicamentos utilizados para mejorar el efecto y la duración de la levodopa incluyen:

Estos medicamentos pueden causar diversos efectos secundarios, incluyendo náuseas, discinesia, dolor de cabeza, presión arterial baja, mareo, retención urinaria o decoloración de la orina, problemas de sueño o insomnio.

La cirugía puede ser una opción para los síntomas motores en el Parkinson avanzado. Las opciones pueden incluir:

Aprenda más

Para aprender más acerca de cómo manejar los síntomas motores de la enfermedad de Parkinson, explore los recursos a continuación o llame a nuestra Línea de Ayuda gratuita al 1-800-4PD-INFO (1-800-473-4636), opción 3 para español:

Podcasts

Episode 190: Raising Awareness About Parkinson’s Through Advocacy

There are countless ways to get involved in raising awareness about Parkinson’s disease (PD)- whether it’s striking a conversation with someone at the grocery store, signing a petition, or meeting with your local members of congress. At its core, policy change begins with meaningful conversations. The more we openly talk about PD, the more we build understanding, urgency, and momentum to shape the future of Parkinson’s care and treatment.

The Parkinson’s Foundation recently launched the Advocacy Center as a resource to support anyone looking to get more involved in advocacy. Through this platform, people can receive the latest policy news and find opportunities to engage their legislators to help make an impact in the Parkinson’s space.

In this episode, we speak with Ken Chason, a Parkinson’s Foundation Ambassador, US Veteran, and person with Parkinson’s, alongside Andi Lipstein Fristedt, the Executive Vice President and Chief Strategy and Policy Officer at the Parkinson’s Foundation. Drawing on their experiences in public service, they highlight the many ways to get involved in advocacy, and why this time is especially critical for accelerating change in the Parkinson’s policy realm

Released: April 14, 2026

Back to Top